It has been proposed that the increase in plasma insulin in people with obesity and insulin resistance is due to the ability of pancreatic β cells and tissues that clear insulin (primarily liver, kidney, and skeletal muscle) to sense the need to secrete more and clear less insulin to maintain normoglycemia (2–6). The gene discussed is INS; the disease is obesity disorder.